$PFE
Added 2024-12-17 12:31:10 +0000 UTC$PFE is up in the PM now after they reaffirms its Full Year 2024 Guidance and offers 2025 guidance and revenue outlook:
'Pfizer 
PFE said Tuesday it continues to expect full year 2024 adjusted earnings in the range of $2.75 to $2.95 per diluted share on a revenue of $61.0 billion to $64.0 billion.
Analysts surveyed by FactSet expect non-GAAP earnings of $2.91 per share on a revenue of $62.89 billion.
The company expects full year 2025 adjusted earnings in the range of $2.80 to $3.00 per diluted share on revenues of $61.0 billion to $64.0 billion.
Analysts surveyed by FactSet expect non-GAAP earnings of $2.86 per share from a revenue of 63.22 billion.'
On the chart, we have been waiting as $PFE continues to hold on the 0.618 Fib since the middle of November at $25
Price needs to break above the previous high at $26 to confirm the reversal and the 1.618 Fib is then the target for Wave 3 at $28.82.
I think the market still needs to hear what RFJ Jr's plans are for the Health Sector before $PFE can start its reversal.
DIVIDEND: 6.7%
Comments
They're talking about a bird flu virus in the US now. Im buying
Justin
2024-12-18 16:31:51 +0000 UTCthis one is interesting for me as well. SCHD is my largest holding and like you mentioned, it holds PFE in it. I think PFE is severely undervalued here(along with alot of other healthcare stocks such as JNJ, MRK, ABT, etc).
Daniel
2024-12-17 12:43:21 +0000 UTCMmm I've been having doubts about this one. I might prefer investing into SCHD insteadl, which has a big allocation in Pfizer amongst others. The dividend of Pfizer and current discount doesn't lie though...
Martechnic
2024-12-17 12:33:35 +0000 UTC
